| Sandoz Pharmaceuticals AG - Irbesartan Sandoz 150, Filmtabletten | | 59183 | | 01 | | Irbesartan Sandoz 150 | | Filmtabletten | | C09CA04 | | Irbesartan | | 25.02.2010 | | |
| | Composition | | irbesartanum 150 mg, cellulosum microcristallinum, lactosum monohydricum 12.673 mg, carmellosum natricum conexum corresp. natrium 0.82 mg, silica colloidalis anhydrica, hypromellosum, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, lactosum monohydricum 0.252 mg, E 171, talcum, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Irbesartan | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Irbesartan | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 0.252 mg | | | Macrogol | 6000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 Comprimé(s) | 11.50 | 28.95 | B | LS | Non | | 002 | 98 Comprimé(s) | 37.12 | 56.95 | B | LS | Non |
|
|
